Interestingly, administration of CAR-NK cells was not associated with the development of CRS, neurotoxicity, or GvHD, and there was no increase in the levels of inflammatory cytokines, including interleukin-6, over baseline. This evidence concerns the gene IL6 and congenital rubella syndrome.